|The hunt for a solution continues|
Professor Dame Sally Davies will become UK special envoy on antimicrobial resistance (AMR), and details have been announced on funding UK’s work in global fight against AMR.
Public Health Minister Seema Kennedy has confirmed the government will be retaining the world-leading expertise of outgoing Chief Medical Officer Professor Dame Sally Davies, as UK special envoy on AMR. Dame Sally will be working across all sectors to deliver a ‘One Health’ response to AMR, which includes health, agriculture and the environment.
Professor Dame Sally played a critical role in putting AMR on the global agenda, driving forward the UK’s world-leading strategy and advising the UN in her role as Co-Convenor for the Interagency Coordination Group on AMR.
Last year the government committed £32m funding to accelerate the UK’s work in the global fight against AMR. Ten leading research centres across the country will now use the funding to explore new ways to inform prescribing and identify patterns of resistance.
The awarded funding will support the development of a state-of-the-art, virtual ‘open access’ centre that will link health outcomes and prescribing data. This technology, led by Public Health England (PHE), will gather real-time patient data on resistant infections, helping clinicians to make more targeted choices about when to use antibiotics and cutting unnecessary prescriptions.
PHE will use £5m in funding to develop a fully functional model ward, the first of its kind in the UK, to better understand how hospital facilities can be designed to improve infection control and reduce the transmission of antibiotic-resistant infections.
Other successful funds include £4.4m to Manchester University to test ‘individualised’ approaches to antibiotic prescribing by bringing together patient care and clinical research, and £3.5m to the University of Liverpool to apply innovative genome sequencing to enable more personalised antibiotic prescribing.The announcement follows the government’s 20-year vision and 5-year national action plan published earlier this year, setting out how the UK will contribute to containing and controlling AMR by 2040.
|Keep Antibiotics Working campaign returns|